This inventor holds 6 USPTO granted patents and 1 EPO patent. Top assignees: Banyu Pharmaceutical Co. Ltd, Msd K.k.. Active years: 2005-2012.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2005-2012
Title: Keita Nagai: Pioneering Innovator in Pharmaceutical Development
Introduction
Keita Nagai, based in Tsukuba, Japan, is an accomplished inventor with a notable portfolio of six patents. His work primarily focuses on drug compounds that target various medical conditions, showcasing his commitment to advancing healthcare through innovative solutions.
Latest Patents
Among his recent contributions to the pharmaceutical field are two significant patents. The first involves aminopyridine derivatives that exhibit selective inhibitory action on Aurora A. These compounds are pertinent in treating numerous diseases associated with neuropeptide Y (NPY), including circulatory diseases like hypertension and heart-related ailments, as well as central nervous system disorders such as depression, anxiety, and epilepsy. The second patent pertains to imidazoline compounds represented by a general formula, designed to address a variety of medical issues, ranging from metabolic diseases like obesity and diabetes to respiratory ailments and reproductive disorders.
Career Highlights
Throughout his career, Keita Nagai has been associated with prominent pharmaceutical companies, including Banyu Pharmaceutical Co., Ltd. and MSD K.K. His contributions to these organizations have been instrumental in the development of effective therapeutic agents, demonstrating his expertise and dedication to medicinal chemistry.
Collaborations
Keita has worked alongside esteemed colleagues, including Nagaaki Sato and Akio Kanatani. These collaborations have fostered an environment of innovation and creativity, enabling significant advancements in the field of pharmaceutical research and development.
Conclusion
In summary, Keita Nagai's inventive spirit and commitment to addressing intricate medical challenges place him at the forefront of pharmaceutical innovation. His numerous patents reflect his crucial role in transforming scientific ideas into practical solutions, potentially improving the quality of life for many individuals affected by various medical conditions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile